Drug Type CAR-T |
Synonyms CI-135 CAR-T Cell(Hrain Biotechnology), FLT3 CAR-T(Hrain Biotechnology) |
Target |
Mechanism FLT3 modulators(Tyrosine-protein kinase receptor FLT3 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Refractory acute myeloid leukemia | Phase 1 | CN | 26 Jan 2022 | |
Relapsing acute myeloid leukemia | Phase 1 | CN | 26 Jan 2022 |